These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 8441822

  • 1. Importance of cholecystokinin in peptide-YY release in response to pancreatic juice diversion.
    Guan D, Rivard N, Maouyo D, Gettys TW, Morisset J.
    Regul Pept; 1993 Feb 18; 43(3):169-76. PubMed ID: 8441822
    [Abstract] [Full Text] [Related]

  • 2. Postprandial peptide YY release is mediated by cholecystokinin.
    McFadden DW, Rudnicki M, Kuvshinoff B, Fischer JE.
    Surg Gynecol Obstet; 1992 Aug 18; 175(2):145-50. PubMed ID: 1636140
    [Abstract] [Full Text] [Related]

  • 3. Endogenous cholecystokinin release responsible for pancreatic growth observed after pancreatic juice diversion.
    Rivard N, Guan D, Maouyo D, Grondin G, Bérubé FL, Morisset J.
    Endocrinology; 1991 Dec 18; 129(6):2867-74. PubMed ID: 1954873
    [Abstract] [Full Text] [Related]

  • 4. The cholecystokinin antagonist L-364,718 inhibits the action of cholecystokinin but not bombesin on rat pancreatic secretion in vivo.
    Anderson L, Dockray GJ.
    Eur J Pharmacol; 1988 Feb 09; 146(2-3):307-11. PubMed ID: 3371402
    [Abstract] [Full Text] [Related]

  • 5. Cholecystokinin receptor antagonism by peptidergic and non-peptidergic agents in rat pancreas.
    Dembinski A, Jaworek J, Konturek PK, Konturek SJ, Warzecha Z.
    J Physiol; 1989 Apr 09; 411():419-35. PubMed ID: 2614728
    [Abstract] [Full Text] [Related]

  • 6. Effects of secretin and caerulein on luminal feedback regulation of pancreatic enzyme secretion in rats.
    Kataoka K.
    Gastroenterol Jpn; 1988 Apr 09; 23(2):174-82. PubMed ID: 3384279
    [Abstract] [Full Text] [Related]

  • 7. Cholecystokinin mediation of colonic absorption via peptide YY: foregut-hindgut axis.
    Liu CD, Hines OJ, Newton TR, Adrian TE, Zinner MJ, Ashley SW, McFadden DW.
    World J Surg; 1996 Feb 09; 20(2):221-7. PubMed ID: 8661821
    [Abstract] [Full Text] [Related]

  • 8. Cholecystokinin receptors and vagal nerves in control of food intake in rats.
    Garlicki J, Konturek PK, Majka J, Kwiecien N, Konturek SJ.
    Am J Physiol; 1990 Jan 09; 258(1 Pt 1):E40-5. PubMed ID: 2301570
    [Abstract] [Full Text] [Related]

  • 9. CCK-antagonist L-364,718: influence on rat pancreatic growth induced by caerulein and bombesin-like peptides.
    Schmidt WE, Choudhury AR, Siegel EG, Löser C, Conlon JM, Fölsch UR, Creutzfeldt W.
    Regul Pept; 1989 Jan 09; 24(1):67-79. PubMed ID: 2544930
    [Abstract] [Full Text] [Related]

  • 10. The effect of endogenous cholecystokinin released by bombesin and trypsin inhibitor on the regeneration of the pancreas.
    Parekh D, Ishizuka J, Townsend CM, Rajaraman S, Thompson JC.
    Ann Surg; 1993 Dec 09; 218(6):735-41. PubMed ID: 8257223
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of cholecystokinin-stimulated pancreaticobiliary output in man by the cholecystokinin receptor antagonist MK-329.
    Cantor P, Olsen O, Gertz BJ, Gjorup I, Worning H.
    Scand J Gastroenterol; 1991 Jun 09; 26(6):627-37. PubMed ID: 1713709
    [Abstract] [Full Text] [Related]

  • 12. Effect of a new potent CCK antagonist, lorglumide, on caerulein- and bombesin-induced pancreatic secretion and growth in the rat.
    Scarpignato C, Varga G, Dobronyi I, Papp M.
    Br J Pharmacol; 1989 Mar 09; 96(3):661-9. PubMed ID: 2470456
    [Abstract] [Full Text] [Related]

  • 13. Effects of peptide YY on CCK/CCK antagonist interactions in cerulein-induced pancreatic injury.
    Tito JM, Rudnicki M, Robinson DC, Guiney WB, Adrian TE, Gold MS.
    Ann N Y Acad Sci; 1995 May 10; 757():410-2. PubMed ID: 7541974
    [No Abstract] [Full Text] [Related]

  • 14. Evidence against cholecystokinin mediation of basal and bombesin-stimulated pancreatic secretion in the rat.
    Wisner JR, Ozawa S, Renner IG.
    Gastroenterology; 1988 Jul 10; 95(1):151-5. PubMed ID: 3371609
    [Abstract] [Full Text] [Related]

  • 15. Effects of intraluminal peptide YY on pancreatic function.
    Brodish RJ, Kuvshinoff BW, Fink AS, McFadden DW.
    Int J Pancreatol; 1992 Oct 10; 12(2):153-60. PubMed ID: 1460330
    [Abstract] [Full Text] [Related]

  • 16. Mediation of trypsin inhibitor-induced pancreatic hypersecretion by secretin and cholecystokinin in rats.
    Watanabe S, Takeuchi T, Chey WY.
    Gastroenterology; 1992 Feb 10; 102(2):621-8. PubMed ID: 1732130
    [Abstract] [Full Text] [Related]

  • 17. PYY potently inhibits pancreatic exocrine secretion mediated through CCK-secretin-stimulated pathways but not 2-DG-stimulated pathways in awake rats.
    Deng X, Guarita DR, Wood PG, Kriess C, Whitcomb DC.
    Dig Dis Sci; 2001 Jan 10; 46(1):156-65. PubMed ID: 11270780
    [Abstract] [Full Text] [Related]

  • 18. Inhibitory effect of somatostatin on cholecystokinin release is independent of luminal cholecystokinin-releasing factor content in conscious rats.
    Miyasaka K, Masuda M, Kanai S, Ohta M, Suzuki S, Tateishi K, Funakoshi A.
    Pancreas; 2001 Nov 10; 23(4):414-20. PubMed ID: 11668212
    [Abstract] [Full Text] [Related]

  • 19. Secretory capacity of pancreatic protein during luminal feedback regulation in conscious rats.
    Okubo K, Masuda M, Miyasaka K, Funakoshi A.
    Jpn J Physiol; 1994 Nov 10; 44(2):205-19. PubMed ID: 7967222
    [Abstract] [Full Text] [Related]

  • 20. Peptide-YY, a new partner in the negative feedback control of pancreatic secretion.
    Guan D, Maouyo D, Taylor IL, Gettys TW, Greeley GH, Morisset J.
    Endocrinology; 1991 Feb 10; 128(2):911-6. PubMed ID: 1989869
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.